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ABSTRACT
Background and Aim: Rheumatic fever is still a common cause of acquired heart disease in children and 
young adult in many developing countries. The aim was to investigate the role of myocardial involvement in the 
hemodynamic changes in patients with acute rheumatic fever using cardiac troponin assay and echocardiography.
Design: A prospective cohort study was designed. Patients and Methods: Thirty-four children with 
acute rheumatic fever, 20 with carditis, and 14 without carditis. Level of cardiac troponin T (cTnT) and 
echocardiographic measurement of left ventricular function were the main outcome measure. Results: The 
level of cardiac troponin in children with carditis was 0.051 ± 0.01 ng/dL, and it was 0.039 ± 0.02 ng/dL 
in those without carditis. The difference is not signiﬁ  cant. In addition, there was no signiﬁ  cant difference 
between the children with carditis and those without carditis regarding left ventricular ejection and shortening 
fractions. Conclusion: There are no signiﬁ  cant echocardiographic measurements abnormalities or cTnT levels 
elevation suggesting clinically relevant hemodynamic abnormalities due to myocardial involvement during 
acute rheumatic fever.
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INTRODUCTION
Rheumatic fever is the most common cause of acquired 
heart disease in children and young adults all over the 
world.[1] Despite a documented decrease in the incidence 
of acute rheumatic fever and a similar documented 
decrease in the prevalence of rheumatic heart diseases 
in industrialized countries during the past ﬁ  ve decades, 
these non-suppurative cardiovascular sequelae of group 
Streptococcal pharyngitis remain medical and public health 
problems in both industrialized and industrializing 
countries even at the beginning of the 21st century. The 
most devastating effects are on children and young adults 
in their most productive years.[2] Rheumatic carditis may be 
associated with pancarditis involving active inﬂ  ammation 
of endocardium, myocardium, and pericardium.[3] Although 
the pathological specimens show interstitial myocardial 
inﬁ  ltrations and Aschoff nodules, myocyte necrosis has 
not been shown even in the presence of congestive heart 
failure. Myocyte necrosis is an important ﬁ  nding in the 
diagnosis of myocarditis.[4] Cardiac troponin T (cTnT) 
is considered as a highly sensitive and speciﬁ  c marker of 
myocardial damage.[5] Cardiac troponins are regulatory 
proteins of the thin actin ﬁ  laments of the cardiac muscle. 
Troponin T and troponin I are highly sensitive and speciﬁ  c 
markers of myocardial injury. Cardiac troponins are 
detected in serum or heparin plasma using monoclonal 
antibodies against several different epitopes of the troponin 
T or I molecule. These antibodies have negligible cross-
reactivity to skeletal muscle.[6] 
Acute valvular disease with heart failure or chronic valvular 
disease account for most of the morbidity and mortality 
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associated with rheumatic fever.[7] Revised guidelines for the 
diagnosis of rheumatic fever indicate that when rheumatic 
fever affects the heart, it usually involves the endocardium, 
myocardium, and pericardium to varying degrees. These 
guidelines also indicate that rheumatic myocarditis, 
although “uncommon” in the absence of severe valvular 
damage, “may contribute” to the genesis of heart failure 
during rheumatic fever.[8] However, the existence of a 
speciﬁ  c primary myocardial involvement contributing to 
the occurrence of heart failure during rheumatic fever is 
controversial and still needs further studies.
The aim of this study was to investigate the role of 
myocardial involvement in the hemodynamic changes in 
patients with acute rheumatic fever using echocardiography 
and cTnT as a speciﬁ  c marker of myocardial damage.
PATIENTS AND METHODS
The study was a prospective cohort study conducted on 
the Suez Canal University Hospital. 
Inclusion criteria
Children admitted with the diagnosis of acute rheumatic 
fever according to the modiﬁ  ed Jones criteria.[9] 
Exclusion criteria
It includes the presence of associated congenital heart 
disease and recurrent or chronic rheumatic valvular 
lesions. For each patient, the following was done: complete 
history and physical examination to detect inclusion and 
exclusion criteria. A blood sample was collected from 
each patient to measure ESR, C-reactive proteins, ASOT, 
and cTnT. Electrocardiography and echocardiography 
were performed for each child. The patients received the 
regular treatment as per the hospital protocol for the cases 
of rheumatic fever. The patients were divided into two 
groups according to the presence or absence of carditis. 
Carditis was deﬁ  ned clinically as the prolongation of PR 
interval in the ECG, sleeping tachycardia out of proportion 
of fever, the presence of a new murmur of aortic or 
mitral regurgitation or the presence of heart failure. This 
was conﬁ  rmed by echocardiography at the time of the 
diagnosis.[10]
Cardiac troponin T assessment
A sample of blood was taken from each child. The 
blood was centrifuged, separated, and frozen at –20 °C 
until batch analysis was performed. Biochemical analysis 
was performed with an Elecsys Troponin T STAT 
Immunoassay (Roche Diagnostics GmbH, Mannheim, 
Germany). This electrochemiluminescent sandwich 
enzyme-linked immunosorbent assay has a lower limit of 
detection of 0.01 ng/mL, and the normal range for cTnT 
is 0.01–0.1 ng/mL.
Echocardiographic assessment
It was performed using the Hewlett-Packard sonos 1800 
series equipped with 3.5–5 MHz transducer. All studies 
included parasternal long and short axis views, apical 
four, five chamber views, subxiphoid four chamber, 
and suprasternal view. Ejection fraction and fractional 
shortening were determined, and the severity of valvular 
regurgitation was graded qualitatively from 0 to 4 (0: absent, 
1: trivial to mild, 2: moderate, 3: moderate to severe, and 
4: severe)[10] 
Statistical analysis
The data were analyzed using the statistical package 
SPSS. Descriptive statistics were used to present the 
characteristics of the study population. Continuous data 
were compared using Student’s t-test. Categorical data were 
compared with a two-tailed c2 test. Statistical signiﬁ  cance 
was accepted as P < 0.05.
Ethical consideration
A written consent was given from participants’ family with 
approval of ethics committee. 
RESULTS
The study group comprised 34 children with ARF, 19 (56%) 
were females and 15 (44%) were males. The mean age of 
the study group was 11.3 ± 2.65 years.
Out of the study population, 20 children (59%) showed 
evidence of carditis, and 14 children (41%) had ARF 
without evidence of carditis.
Table 1 shows the characteristics of the study population. 
From this table, we can see that there is no signiﬁ  cant 
difference between the two groups of children (with and 
without carditis) regarding the age, sex, CRP, and ESR. 
The PR interval on ECG was prolonged in the group 
of patients with carditis (0.17 ± 0.03 s) compared to the 
group without carditis (0.10 ± 0.05 s). The difference was 
statistically signiﬁ  cant. In addition, the resting pulse rate was 
signiﬁ  cantly higher in the group of patients with carditis 179
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Table 1: Clinical and biological characteristics of the study groups
ARF with carditis, n = 20 (59%) ARF without carditis, n = 14 (41%) P
Age (years) 11.5 ± 4.6 10.9 ± 5.3 0.374
Sex
     Female






CRP (mg/dL) 6.5 ± 5.2 7.1 ± 4.9 0.153
ESR (mm/h) 69 ± 21.3 58 ± 26.8 0.215
PR (s) 0.17 ± 0.03 0.10 ± 0.05 0.021*
Heart rate (b/min) 109.3 ± 15.7 89.6 ± 19.4 0.013*
*Signiﬁ  cant difference.
Table 2: Distribution of valvular lesions among children with carditis
Grade 1  (trivial to mild) Grade 2 (moderate) Grade 3 (moderate to severe) Grade 4 (severe)
MR (n) 4 7 4 0
AR (n) 1 1 0 0
MR + AR (n) 0 3 0 0
MR: Mitral regurgitation; AR: Aortic regurgitation; N: Number of children.
(109.3 ± 15.7 beats/min), compared to those without 
carditis (89.6 ± 19.4 beats/min).
The distribution of valvular lesions in children with carditis 
is shown in Table 2. Fifteen children had isolated mitral 
regurgitation (four children grade 1, seven children grade 
2, and four children grade 3). Another three patients had 
both mitral and aortic regurgitation (grade 2). Isolated 
aortic regurgitation was present in two children (one child 
grade 1, and one child grade 2). Among the 20 children 
with carditis, heart failure was present in ﬁ  ve children with 
mitral regurgitation.
Table 3 shows the cTnT level in both groups of children 
with ARF. The mean level of cTnT in patients with carditis 
is 0.051 ± 0.01 ng/mL, while the mean level of cTnT 
in patients without carditis is 0.039 ± 0.02 ng/mL. The 
difference is not signiﬁ  cant (P > 0.05).
Table 4 shows the echocardiographic measurements in the 
two groups of children with ARF. We can see from this 
table that the left ventricular ejection fraction is 59.2 ± 
7.3% in patients with carditis and 65.6 ± 6.4% in patients 
without carditis. The difference is not signiﬁ  cant (P > 0.05). 
In addition, there was no signiﬁ  cant difference between 
the two groups regarding the fractional shortening which 
was 31.8 ± 6.2% in the group of children with carditis and 
37.5 ± 6.4% in the children without carditis (P > 0.05).
DISCUSSION
Despite pathologic evidence of myocardial inﬂ  ammation, 
the signiﬁ  cance of myocarditis in children with acute 
rheumatic carditis remains controversial.[11] The guidelines 
for the diagnosis of rheumatic fever indicated that 
rheumatic myocarditis, although uncommon, in the absence 
of severe valvular damage may have contributed to the 
genesis of heart failure during rheumatic fever.[8]
In this study, we could not ﬁ  nd any biochemical alteration 
or echocardiographic measurements change suggestive 
of signiﬁ  cant hemodynamic effects due to myocardial 
involvement. No statistically signiﬁ  cant difference was 
found in the level of cTnT between patients with and 
without rheumatic carditis. Furthermore, all patients 
showed cTnT level within the normal range even in those 
with heart failure. Cardiac troponin T is considered as one 
of the new “gold markers” of ischemic myocardial injury 
and has been detected as a sensitive and speciﬁ  c marker 
of even subclinical myocardial injury. It is also used in the 
diagnosis and monitoring of nonischemic myocardial injury, 
like myocarditis.[12] 
In addition, the echocardiographic study failed to show 
any signiﬁ  cant difference in the left ventricular ejection and 
shortening fractions between children with and without 
Table 4: Functional echocardiography data
ARF with carditis 
n = 20 (59%)
ARF without 




59.2 ± 7.3 65.6 ± 6.4 0.087
Fractional 
shortening (%)
31.8 ± 6.2 37.5 ± 6.4 0.216
Table 3: Cardiac troponin T level in the study groups
ARF with 
carditis, n = 20 
(59%)
ARF without 
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rheumatic carditis whether or not they had congestive heart 
failure. Our results are in agreement with Tavli et al.,[13] 
who showed that the level of cTnI is not elevated in acute 
rheumatic fever in children with and without carditis. In 
addition, they failed to show any echocardiographic signs 
of myocardial involvement in their study on rheumatic 
fever in children. Alehan et al.[14] also demonstrated that 
serum cTnT concentration does not increase above normal 
limits in rheumatic carditis with or without heart failure, 
also they could not ﬁ  nd any signiﬁ  cant change in function 
due to myocarditis using echocardiography. Kamblock 
et al.[15] examined a large series of children with ARF 
(95 children), they neither detected cTnI elevations nor 
echocardiographic abnormalities suggesting signiﬁ  cant 
hemodynamic changes due to myocardial involvement 
during rheumatic fever, in patients with carditis even if 
they had congestive heart failure. Congestive heart failure 
was always related to severe valve regurgitation not to 
myocarditis. The same results were shown by Williams et 
al.,[4] who demonstrated that serum cTnI was not elevated 
in patients with acute rheumatic fever. They stated that the 
fact that levels of cardiac troponin I are not elevated in the 
serum of children with acute rheumatic carditis suggesting 
that there is minimal myocyte necrosis in this setting.
The low cTnT values, especially in the presence of active 
carditis, dispute signiﬁ  cant ischemic myocyte injury.[16] 
Myocardial necrosis is not prominent despite intensive 
inflammation in ARF.[17] ARF is mainly a disease of 
connective tissue, and endocarditis is the prominent 
factor.[18] This may explain the normal concentrations 
of cTnT found in patients with ARF carditis. Aschoff 
nodules are the histological hallmark of rheumatic fever, 
and have been identiﬁ  ed in left atrial appendages and 
ventricular myocardium of patients with rheumatic fever 
and rheumatic heart disease.[19] However, the presence of 
Aschoff nodules in the ventricular myocardium does not 
signify that they play a role in the genesis of congestive 
heart failure during the acute stage of the disease.[8]
We can conclude that this study did not demonstrate 
an elevated cTnT level suggesting clinically relevant 
myocardial involvement during acute rheumatic fever even 
in patients with severe carditis and congestive heart failure. 
In addition, we failed to show signiﬁ  cant difference in 
echocardiographic measurements between patients with 
and without carditis. These ﬁ  ndings substantiate the view 
that myocardial involvement during acute rheumatic fever 
has no signiﬁ  cant hemodynamic effects and does not 
play a role in the development of heart failure in patients 
with rheumatic carditis. Heart failure is related mainly to 
the extent of valvular lesions rather than the myocardial 
involvement. 
However, among study limitations are rather small 
number of studied population. Further studies are needed 
to conﬁ  rm that myocardial involvement during acute 
rheumatic fever is not relevant in the development of heart 
failure in patients with rheumatic fever.
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